MiR-378 as a biomarker for response to anti-angiogenic treatment in ovarian cancer

John K. Chan*, Tuyen K. Kiet, Kevin Blansit, Rashmi Ramasubbaiah, Joan F. Hilton, Daniel S. Kapp, Daniela Matei

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

58 Scopus citations

Fingerprint

Dive into the research topics of 'MiR-378 as a biomarker for response to anti-angiogenic treatment in ovarian cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences